Genetics Generation Advancement Corp. (4160.TWO)

TWD 70.2

(-2.9%)

Revenue Summary of Genetics Generation Advancement Corp.

  • Genetics Generation Advancement Corp.'s latest annual revenue in 2023 was 592.5 Million TWD , up 8.16% from previous year.
  • Genetics Generation Advancement Corp.'s latest quarterly revenue in 2024 Q2 was 169.6 Million TWD , up 1.64% from previous quarter.
  • Genetics Generation Advancement Corp. reported a annual revenue of 547.8 Million TWD in annual revenue 2022, up 5.45% from previous year.
  • Genetics Generation Advancement Corp. reported a annual revenue of 519.51 Million TWD in annual revenue 2021, up 17.24% from previous year.
  • Genetics Generation Advancement Corp. reported a quarterly revenue of 166.87 Million TWD for 2024 Q1, up 5.8% from previous quarter.
  • Genetics Generation Advancement Corp. reported a quarterly revenue of 157.73 Million TWD for 2023 Q4, up 1.9% from previous quarter.

Annual Revenue Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Revenue of Genetics Generation Advancement Corp. (2023 - 2019)

Year Revenue Revenue Growth
2023 592.5 Million TWD 8.16%
2022 547.8 Million TWD 5.45%
2021 519.51 Million TWD 17.24%
2020 443.13 Million TWD 3.2%
2019 429.38 Million TWD 0.0%

Peer Revenue Comparison of Genetics Generation Advancement Corp.

Name Revenue Revenue Difference
BIONET Corp. 1.12 Billion TWD 47.441%
DIVA Laboratories, Ltd. 893.84 Million TWD 33.713%
Welgene Biotech Co.,Ltd. 280.54 Million TWD -111.195%
Puriblood Medical Co., Ltd. 125.26 Million TWD -372.986%
TFBS Bioscience Inc. 231.91 Million TWD -155.48%